Arne Melander
#194,004
Most Influential Person Across History
Arne Melander's AcademicInfluence.com Rankings
Arne Melandermedical Degrees
Medical
#3305
Historical Rank
Public Health
#460
Historical Rank
Epidemiology
#571
Historical Rank
Download Badge
Medical
Arne Melander's Degrees
- Masters Epidemiology University of Gothenburg
Why Is Arne Melander Influential?
(Suggest an Edit or Addition)Arne Melander's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Variation in antibiotic use in the European Union (2001) (742)
- Systematic Review of the Incidence and Characteristics of Preventable Adverse Drug Events in Ambulatory Care (2007) (385)
- Ten-year Follow-up of Subjects with Impaired Glucose Tolerance: Prevention of Diabetes by Tolbutamide and Diet Regulation (1980) (307)
- Therapeutic Comparison of Metformin and Sulfonylurea, Alone and in Various Combinations: A double-blind controlled study (1994) (251)
- Enhancement of the bioavailability of propranolol and metoprolol by food (1977) (221)
- Postural and symptomatic improvement after physiotherapy in patients with dizziness of suspected cervical origin. (1996) (201)
- Effects of total energy withdrawal (fasting) on thelevels of growth hormone, thyrotropin, cortisol, adrenaline, noradrenaline, T4, T3, and rT3 in healthy males. (2009) (149)
- Influence of cigarette smoking on goiter formation, thyroglobulin, and thyroid hormone levels in women. (1984) (136)
- Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study. (1995) (129)
- Influence of Food Intake on Presystemic Clearance of Drugs (1983) (123)
- Comparison of dose standard units for drug utilisation studies (1996) (122)
- Low systolic blood pressure is associated with impaired cognitive function in the oldest old: longitudinal observations in a population-based sample 80 years and older (2007) (118)
- Prescriptions with potential drug interactions dispensed at Swedish pharmacies in January 1999: cross sectional study (2001) (116)
- Hypoglycemic Activity of Glyburide (Glibenclamide) Metabolites in Humans (1994) (115)
- Increased mortality in Type II diabetic patients using sulphonylurea and metformin in combination: a population-based observational study (2000) (107)
- VIP occurs in intrathyroidal nerves and stimulates thyroid hormone secretion (1980) (101)
- Drug‐related problems and pharmacy interventions in community practice (1999) (100)
- HYPERGLYCAEMIA AND ABSORPTION OF SULPHONYLUREA DRUGS (1989) (90)
- Does aspirin protect against Alzheimer's dementia? A study in a Swedish population-based sample aged ≥80 years (2003) (89)
- Body mass index and disability pension in middle-aged men--non-linear relations. (1996) (88)
- Antihyperglycaemic Efficacy, Response Prediction and Dose—Response Relations of Treatment with Metformin and Sulphonylurea, Alone and in Primary Combination (1994) (85)
- Exocytosis of protein into the thyroid follicle lumen: an early effect of TSH. (1975) (81)
- Dose-Dependent Effects of Glyburide on Insulin Secretion and Glucose Uptake in Humans (1991) (78)
- Diastolic blood pressure and area of residence: multilevel versus ecological analysis of social inequity (2001) (76)
- Associations between smoking and β‐cell function in a non‐hypertensive and non‐diabetic populationSkaraborg Hypertension and Diabetes Project (2000) (76)
- Repeat prescriptions: refill adherence in relation to patient and prescriber characteristics, reimbursement level and type of medication. (2005) (75)
- Thiazolidinediones for type 2 diabetes (2000) (75)
- Factors influencing the detection rate of drug‐related problems in community pharmacy (1999) (74)
- Enhancement of hydralazine bioavailability by food (1977) (72)
- Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment. (1987) (71)
- Concentration-effect relations of glibenclamide and its active metabolites in man: modelling of pharmacokinetics and pharmacodynamics. (1997) (70)
- Risk factor clustering in patients with hypertension and non‐insulin‐dependent diabetes mellitus. The Skaraborg Hypertension Project (1998) (67)
- High-performance liquid chromatographic determination of glipizide and some other sulfonylurea drugs in serum. (1979) (67)
- Sympathetic innervation of the mouse thyroid and its significance in thyroid hormone secretion. (1974) (67)
- Pharmacokinetics of glibenclamide and its metabolites in diabetic patients with impaired renal function (1998) (67)
- Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitus (1978) (64)
- Sympathetic activation of thyroid hormone secretion in mice. (1972) (64)
- Glucose tolerance and mortality, including a substudy of tolbutamide treatment (1997) (64)
- What Is the Benefit of Increasing the Sulfonylurea Dose? (1993) (63)
- Presence and influence of cholinergic nerves in the human thyroid. (1979) (61)
- Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3-day intensified treatment period. (1994) (61)
- Use of calcium channel blockers and risk of suicide: ecological findings confirmed in population based cohort study (1998) (61)
- Electrophysiological studies in newly onset type 2 diabetes without visible vascular retinopathy (2011) (61)
- Peroxisome proliferator-activated receptor-γPro12Ala polymorphism and the association with blood pressure in type 2 diabetes: Skaraborg Hypertension and Diabetes Project (2003) (60)
- Bioavailability, Pharmacokinetics and Effects of Glipizide in Type 2 Diabetics (1982) (60)
- Blood levels of 3,5,3'-triiodothyronine and thyroxine: differences between children, adults, and elderly subjects. (2009) (58)
- Slow Elimination of Glyburide in NIDDM Subjects (1994) (58)
- Reduction of isoniazid bioavailability in normal men by concomitant intake of food. (2009) (57)
- Effects of antithyroid drugs on lymphocyte function in vitro. (1980) (56)
- Kinetics-effect relations of insulin-releasing drugs in patients with type 2 diabetes: brief overview. (2004) (55)
- Influence of smoking on thyroid activity. (2009) (55)
- Food-induced reduction in bioavailability of atenolol (1979) (54)
- Sympathetic innervation of the normal human thyroid. (1974) (54)
- Incidence of myocardial infarction in elderly men being treated with antihypertensive drugs: population based cohort study (1996) (53)
- Induced unidirectional transport of protein into the thyroid follicular lumen. (1974) (52)
- British Medical Journal (1990) (51)
- Determination of glibenclamide and its two major metabolites in human serum and urine by column liquid chromatography. (1991) (50)
- Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use. (1989) (49)
- Concomitant food intake can increase the bioavailability of propranolol by transient inhibition of its presystemic primary conjugation (1986) (48)
- Enhancement by food of canrenone bioavailability from spironolactone (1977) (48)
- Beta2-adrenergic stimulation of thyroid hormone secretion. (1975) (48)
- Interactions between catecholamines, 5-hydroxytryptamine and TSH on the secretion of thyroid hormone. (1972) (47)
- Sympathetic innervation of the thyroid: variation with species and with age. (1975) (45)
- Thyroid hormone secretion. Its regulation by intrathyroidal amines. (1971) (45)
- Excretion of paracetamol in human breast milk (2004) (44)
- Intracellular distribution of amines and calcitonin in the sheep thyroid gland. (1972) (43)
- Endocytosis of thyroglobulin and release of thyroid hormone in mice by catecholamines and 5-hydroxytryptamine. (1970) (43)
- Glycaemic control, disease duration and β‐cell function in patients with Type 2 diabetes in a Swedish community. Skaraborg Hypertension and Diabetes Project (2002) (42)
- Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide (2005) (42)
- Influence of the sympathetic nervous system on the secretion and metabolism of thyroid hormone. (1977) (42)
- Utilisation of antihyperglycaemic drugs in ten European countries: different developments and different levels (2006) (41)
- Comparison of the kinetics of glyburide and its active metabolites in humans (1995) (41)
- Influence of food intake on the absorption and effect of glipizide in diabetics and in healthy subjects (1980) (40)
- Sympathetic regulation of thyroid hormone secretion. (1974) (40)
- Effects of glipizide and food intake on the blood levels of glucose and insulin in diabetic patients. (2009) (39)
- ATRIAL NATRIURETIC PEPTIDE AND BLOOD PRESSURE IN A GEOGRAPHICALLY DEFINED POPULATION (1987) (39)
- Equianalgesic effects of paracetamol and indomethacin in rheumatoid arthritis. (1988) (39)
- Vasoactive intestinal peptide stimulation of human thyroid cell function. (1984) (38)
- Drug prescription attitudes and behaviour of general practitioners (2004) (38)
- Association of outpatient utilisation of non-steroidal anti-inflammatory drugs and hospitalised heart failure in the entire Swedish population (2001) (38)
- Survival in patients with type 2 diabetes in a Swedish community: skaraborg hypertension and diabetes project. (2002) (38)
- Intrathyroidal amines in the regulation of thyroid activity. (1975) (38)
- Influence of food on the presystemic metabolism of drugs. (1988) (37)
- Comparison of Pharmacokinetics, Metabolic Effects and Mechanisms of Action of Glyburide and Glipizide During Long-Term Treatment (1987) (37)
- Intrathyroidal amines and the synthesis of thyroid hormone. (1973) (37)
- Understanding adherence to official guidelines on statin prescribing in primary health care—a multi-level methodological approach (2005) (36)
- Retinopathy in subjects with impaired fasting glucose: the NANSY‐Eye baseline report (2008) (36)
- Incidence of and reasons for disability pension in a Swedish cohort of middle-aged men (1994) (35)
- Comparison of Excess Costs of Care and Production Losses Because of Morbidity in Diabetic Patients (1994) (35)
- Effects of dexamethasone, desoxycorticosterone, and ACTH on serum concentrations of thyroxine, 3,5,3'-triiodothyronine and 3,3',5'-triiodothyronine. (2009) (35)
- In vivo action of vinblastine on thyroid ultrastructure and hormone secretion. (1974) (35)
- Clinical pharmacology of sulfonylureas. (1987) (35)
- Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics (2004) (35)
- Comparative single-dose kinetics and effects of four sulfonylureas in healthy volunteers. (2009) (35)
- Oral Antidiabetic Drugs: an Overview (1996) (34)
- Intra-urban variation of antibiotic utilization in children: influence of socio-economic factors (1998) (34)
- Accumulation of atenolol and metoprolol in human breast milk (2004) (34)
- Bioavailability of propylthiouracil: Interindividual variation and influence of food intake. (2009) (33)
- Thyroid and adrenomedullary reactions during sleep deprivation. (1979) (32)
- Effects and serum levels of glibenclamide and its active metabolites in patients with type 2 diabetes (2001) (32)
- Refill adherence of antihyperglycaemic drugs related to glucose control (HbA1c) in patients with type 2 diabetes (2007) (32)
- Significance of thyroid mast cells in thyroid hormone secretion. (1972) (32)
- Refill non-adherence to repeat prescriptions leads to treatment gaps or to high extra costs (2007) (31)
- Sulfonylureas: Basic Aspects and Clinical Uses (2004) (31)
- Socioeconomic factors, morbidity and drug utilization—an ecological study (1998) (30)
- Verapamil Inhibits L-type Calcium Channel Mediated Apoptosis in Human Colon Cancer Cells (2008) (30)
- Aminergic regulation of thyroid activity: importance of the sympathetic innervation and of the mast cells of the thyroid gland. (2009) (29)
- On the bioassay of thyrotrophin in plasma. (1965) (29)
- Anxiolytic-hypnotic drug use associated with trust, social participation, and the miniaturization of community: a multilevel analysis. (2006) (29)
- Bioavailability of acetylsalicylic acid and salicylic acid from rapid-and slow-release formulations, and in combination with dipyridamol (2004) (29)
- Is There a Concentration-Effect Relationship for Sulphonylureas? (1998) (28)
- Metabolic disorders associated with uncontrolled hypertension. (2003) (28)
- TSH-induced appearance and stimulation of amine-containing mast cells in the mouse thyroid. (1971) (28)
- Physiotherapy after total hip replacement for primary arthrosis. (1988) (27)
- IS THE BLOOD CHLORPROPAMIDE CONCENTRATION CRITICAL IN CHLORPROPAMIDE ALCOHOL FLUSH? (1981) (27)
- Prescribing, prescription costs and adherence to formulary committee recommendations: long-term differences between physicians in public and private care (2001) (27)
- Secretion of thyroxine, 3,5,3'-triiodothyronine and 3,3'5'-triiodothyronine in euthyroid man. (1977) (27)
- Evaluation of spiramycin as a therapeutic agent for elimination of nasopharyngeal pathogens. Possible use of spiramycin for middle ear infections and for gonococcal and meningococcal nasopharyngeal carriage. (1978) (26)
- Influence of histamine- and 5-hydroxytryptamine-containing thyroid mast cells on thyroid blood flow and permeability in the rat. (1975) (25)
- Transplacental passage and breast milk concentrations of hydralazine (2004) (25)
- Active and inactive thyroid hormone levels in elective and acute surgery. (1979) (25)
- Benzodiazepine prescribing patterns in a high-prescribing scandinavian community (2004) (24)
- Influence of food on the absorption of phenytoin in man (1979) (24)
- Influence of wheat bran and of a bulk-forming ispaghula cathartic on the bioavailability of digoxin in geriatric in-patients. (1987) (24)
- Reduction of Paracetamol and Aspirin Metabolism During Viral Hepatitis (1986) (24)
- Differences in treatment and metabolic abnormalities between normo- and hypertensive patients with type 2 diabetes: the Skaraborg Hypertension and Diabetes Project. (1999) (24)
- Inhibition by somatostatin of mouse thyroid activity following stimulation by thyrotrophin, isoprenaline and dibutyryl cyclic-AMP. (1977) (24)
- Prolonged elimination of tolbutamide in a premature newborn with hyperinsulinaemic hypoglycaemia. (1998) (24)
- Clinical pharmacology of glipizide. (1983) (23)
- Comparison of energy and nutrient intakes in women with high and low blood pressure levels. (2009) (23)
- Increased risk of ischaemic heart disease mortality in elderly men using anxiolytics-hypnotics and analgesics (2004) (23)
- Efficacy of Dietary Regulation in Primary Health Care Patients with Hyperglycaemia Detected by Screening (1988) (23)
- High-pressure liquid chromatographic determination of acetylsalicylic acid, salicylic acid, diflunisal, indomethacin, indoprofen and indobufen (2004) (23)
- Utilisation of antibiotics in young children: opposite relationships to adult educational levels in Danish and Swedish counties (2003) (23)
- Can sulphonylurea addition to lifestyle changes help to delay diabetes development in subjects with impaired fasting glucose? The Nepi ANtidiabetes StudY (NANSY) (2011) (23)
- Impaired effect of sulfonylurea following increased dosage (2004) (22)
- AMINES AND MOUSE THYROID ACTIVITY (1969) (22)
- Pharmacokinetics and effects of glibenclamide in two formulations, HB 419 and HB 420, in type 2 diabetes. (1983) (21)
- Effect of sulphonylurea on glucose-stimulated insulin secretion in healthy and non-insulin dependent diabetic subjects: a dose-response study (2004) (21)
- Pharmacodynamics and pharmacokinetics of intravenous glibenclamide in Caucasian and Chinese patients with type-2 diabetes (2000) (21)
- Divergent changes of serum 3,5,3'-triiodothyronine and 3,3',5'-triiodothyronine in patients with acute myocardial infarction. (2009) (21)
- Impaired glucose metabolism and obesity in Swedish patients with borderline isolated systolic hypertension: Skaraborg Hypertension and Diabetes Project (2001) (20)
- Transplacental passage of atenolol in man (1978) (20)
- TSH-induced release of 5-hydroxytryptamine and histamine rat thyroid mast cells. (1972) (19)
- Mortality in elderly men with low psychosocial coping resources using anxiolytic - hypnotic drugs (2000) (19)
- Bioavailability of oxazepam: absence of influence of food intake. (2009) (19)
- Dynamic training and circulating levels of corticotropin-releasing factor, beta-lipotropin and beta-endorphin in rheumatoid arthritis (1990) (19)
- Comparative in vitro effects and in vivo kinetics of antithyroid drugs (1980) (18)
- Influence of food on the bioavailability of "real" and "apparent" hydralazine from conventional and slow-release preparations. (1982) (18)
- Antihypertensive drug treatment in a Swedish community: Skaraborg hypertension and diabetes project (2002) (18)
- The influence of glipizide on early insulin release and glucose disposal before and after dietary regulation in diabetic patients with different degrees of hyperglycaemia (2004) (18)
- Absorption and elimination of D-propoxyphene, acetyl salicylic acid, and phenazone in a combination tablet (Doleron): comparison between young and elderly subjects. (2009) (17)
- Improved effect of glibenclamide on administration before breakfast (2004) (17)
- Effects and pharmacokinetics of oral glibenclamide and glipizide in Caucasian and Chinese patients with type-2 diabetes (2000) (17)
- Effect of vitamin D2 stimulation on amine stores and secretory granules in the calcitonin cells of the mouse (2004) (17)
- On the influence of concomitant food intake on sulfonamide bioavailability. (2009) (17)
- Stimulation of peripheral T3 formation by oral but not by intravenous glucose administration in fasted subjects. (1977) (17)
- Acute Actions of Sulfonylurea Drugs During Long-Term Treatment of NIDDM (1990) (16)
- Efficacy, effectiveness and safety of sulphonylurea–metformin combination therapy in patients with type 2 diabetes (2002) (16)
- THYROID STIMULATION BY TSH AND MONOAMINES: INTERACTIONS WITH ALPHA AND BETA ADRENERGIC BLOCKING DRUGS (1969) (16)
- Inverse association between plasma homocysteine, sulphonylurea exposure and physical activity: a community‐based sample of type 2 diabetes patients in the Skaraborg hypertension and diabetes project (2005) (15)
- Bioavailability of D-propoxyphene, acetyl salicylic acid, and phenazone in a combination tablet (Doleron): interindividual variation and influence of food intake. (2009) (15)
- Influence of sulfonylureas on the secretion, disposal and effect of insulin (2004) (15)
- Influence of beta-adrenoceptor blocking agents on lymphocyte function in vitro. (1982) (15)
- Effect of polyphloretin phosphate on the induction of thyroid hormone secretion by various thyroid stimulators. (1973) (15)
- Sulphonylurea Antidiabetic Drugs (2012) (15)
- Mechanisms and variations in the food effect on propranolol bioavailability (2006) (15)
- SALICYLATE INHIBITION OF ANTIPLATELET EFFECT OF ASPIRIN (1981) (15)
- Influence of food and age on the single-dose kinetics and effects of tolbutamide and chlorpropamide (1980) (14)
- Concomitant depletion of dopamine and secretory granules from cells in the ultimobranchial gland of vitamin D2-treated chicken (2004) (14)
- Age standardisation of drug utilisation: comparisons of different methods using cardiovascular drug data from Sweden and Spain (2004) (13)
- Opposite effects of carbohydrate and protein on phenytoin absorption in man. (1983) (13)
- Comparison of a narcotic (oxicone) and a non-narcotic anti-inflammatory analgesic (indoprofen) in the treatment of renal colic. (1985) (13)
- Survival in patients with hypertension treated in primary care A population-based follow-up study in the Skaraborg Hypertension and Diabetes Project (2004) (13)
- Pharmacokinetic interaction of acetylsalicylic acid and dipyridamole. (1985) (13)
- Impaired cognitive function in elderly men exposed to benzodiazepines or other anxiolytics (1997) (13)
- Effects of antihyperglycaemic therapies on proinsulin and relation between proinsulin and cardiovascular risk factors in type 2 diabetes (1999) (12)
- EVITA: a tool for the early EValuation of pharmaceutical Innovations with regard to Therapeutic Advantage (2010) (12)
- 10 Sulphonylureas in the treatment of non-insulin-dependent diabetes (1988) (12)
- Will Sulfonylurea Treatment of Impaired Glucose Tolerance Delay Development and Complications of NIDDM? (1990) (12)
- DIVERGENT EFFECTS OF 6-PROPYLTHIOURACIL ON 3,5,3′-TRIIODOTHYRONINE (T3) AND 3,3′,5′-TRIIODOTHYRONINE (RT3) SERUM LEVELS IN MAN (1977) (12)
- Low-dose aspirin to pregnant women: Single dose pharmacokinetics and influence of short term treatment on bleeding time (1994) (12)
- Pharmacokinetics of dixyrazine: low bioavailability, improved by food intake. (1985) (12)
- A Placebo‐Controlled Dose‐Response Study of Felodipine Extended Release in Hypertensive Patients (1989) (11)
- Neighborhood social participation, use of anxiolytic-hypnotic drugs, and women's propensity for disability pension: a multilevel analysis (2006) (11)
- Varying distribution of acetylation phenotypes in RA patients with and without Sjögren's syndrome. (1981) (11)
- 35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts. (1999) (11)
- Predictors of acute myocardial infarction mortality in hypertensive patients treated in primary care (2007) (11)
- Appearance of amine-containing mast cells in the mouse thyroid induced by the human long-acting thyroid stimulator (LATS). (1973) (11)
- Sulphonylurea dose–response relationships: relation to clinical practice (2000) (11)
- Concomitant food intake does enhance the bioavailability and effect of hydralazine (1985) (11)
- Utilisation of codeine and propoxyphene: geographic and demographic variations in prescribing, prescriber and recipient categories (1999) (11)
- Indobufen interacts with the sulphonylurea, glipizide, but not with the beta-adrenergic receptor antagonists, propranolol and atenolol. (1984) (11)
- Do Sulfonylureas Influence Hepatic Insulin Clearance? (1988) (11)
- Lack of primary effect of sulphonylurea (glipizide) on plasma lipoproteins and insulin action in former Type 2 diabetics with attenuated insulin secretion (2004) (11)
- Bioavailability of metronidazole in fasting and non-fasting healthy subjects and in patients with Crohn's disease (1977) (10)
- Therapeutic equivalence of once- and thrice-daily glipizide (2004) (10)
- Acetylator phenotyping: A comparison of the isoniazid and dapsone tests (2004) (10)
- Primary non-compliance with automated prescription transmittals from health care centres in Sweden (2002) (10)
- Laxative treatment elevates plasma homocysteine: a study on a population-based Swedish sample of old people (2004) (10)
- Interactions of adrenergic blocking drugs with the in vivo release of thyroid hormone induced by thyrotrophin and the long-acting thyroid stimulator. (1971) (10)
- Antidepressants in suicide: differences in fatality and drug utilisation (2004) (9)
- Clinical pharmacology of oral antidiabetic agents (1983) (9)
- Carbamazepine kinetics and adverse effects during and after ethanol exposure in alcoholics and in healthy volunteers (2005) (9)
- Presence and influence of cholinergic nerves in the mouse thyroid. (1979) (9)
- The Acute Effect of Preprandial Exogenous and Endogenous Sulphonylurea‐stimulated Insulin Secretion on Postprandial Glucose Excursions in Patients with Type 2 Diabetes (1993) (8)
- Increased Introduction, Advertising, and Sales of Preventive Drugs During 1986–2002 in Sweden (2006) (8)
- Large intercommunity difference in cardiovascular drug consumption: relation to mortality, risk factors and socioeconomic differences (2005) (8)
- Review of previous impaired glucose tolerance intervention studies. (1996) (8)
- Comparison of diflunisal and acetylsalicylic acid in patients with rheumatoid arthritis. (1981) (8)
- The relationship between early insulin release and glucose tolerance in healthy subjects. (1993) (8)
- Intercommunity variations in antidiabetic drug utilization and in prevalence of diabetes mellitus (1994) (8)
- Use of Generic Drugs and Effects of the Reference Price System in Sweden (2000) (8)
- Studies on the thyroid activity in the mouse. 2. The effects of stress and other changes in corticotrophin secretion. (1968) (8)
- Serum and saliva concentrations of sulfamethoxazole and trimethoprim in adults and children: relation between saliva concentrations and in vitro activity against nasopharyngeal pathogens. (1983) (7)
- Effects and plasma levels of propranolol and metoprolol in hyperthyroid patients (1980) (7)
- Effects of total energy withdrawal fasting on the levels of growth hormone thyrotropin cortisol adrenaline noradrenaline thyroxine tri iodo thyronine and reverse tri iodo thyronine in healthy males (1977) (7)
- Use of calcium channel blockers as antihypertensives in relation to mortality and cancer incidence: a population‐based observational study (2002) (7)
- Actions and interactions of acetylsalicylic acid, salicylic acid and diflunisal on platelet aggregation (2004) (6)
- Long-term effects of glipizide on insulin secretion and blood glucose control in patients with non-insulin-dependent diabetes mellitus (2004) (6)
- Amines and mouse thyroid activity: a thyroid-stimulating effect of 5-hydroxytryptamine and dopamine. (1969) (6)
- Significance of thyroid mast cells in the regulation of thyroid activity (1973) (6)
- Depletion of secretory granules, calcitonin, and formaldehyde-ozone-induced fluorescence from cat thyroid C cells by vitamin D2 treatment (1973) (6)
- Influence of food intake on the bioavailability of zuclopenthixol. (1987) (5)
- Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol (2004) (5)
- Sulfonylureas and meglitinides: insights into physiology and translational clinical utility (2015) (5)
- Differences in pharmacotherapy and in glucose control of type 2 diabetes patients in two neighbouring towns: a longitudinal population‐based study (2001) (5)
- Sulphonylureas in the treatment of non-insulin-dependent diabetes. (1988) (5)
- Different effects of different nutrients on theophylline absorption in man. (1985) (5)
- Influence of food intake on the bioavailability of zimeldine and its active metabolite, norzimeldine. (1983) (5)
- How to screen for diabetes mellitus (1983) (5)
- Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal (2004) (5)
- Utilization of cardiovascular drugs (blood pressure lowering drugs, lipid lowering drugs and nitrates) and mortality from ischaemic heart disease and stroke An ecological analysis based on Sweden's municipalities (1999) (5)
- Chlorpropamide-alcohol flush: Significance of body weight, sex and serum chlorpropamide level (2004) (5)
- Influence of food and of age on nitrazepam kinetics. (1982) (5)
- Pharmacokinetics and Effects of Glipizide in Healthy Volunteers (1991) (4)
- Drug Selection in the Treatment of Pregnancy Hypertension: A survey (1984) (4)
- Significance of Amines in Polypeptide-Secreting Endocrine Cells with Special Regard to the C Cells (1972) (4)
- 3,4-Dihydroxypyridine: a potential antithyroid drug. (1987) (4)
- Drug compliance in diabetics. (1978) (4)
- Fetal Heart Rate During Treatment of Maternal Hypertension with Beta‐Adrenergic Antagonists: A preliminary report (1984) (4)
- Food intake and drug bioavailability. (1981) (4)
- Amines and mouse thyroid activity: release of thyroid hormone by catecholamines and indoleamines and its inhibition by adrenergic blocking drugs. (1970) (4)
- Influence of food and different nutrients on drug bioavailability. (1984) (4)
- Blood pressure and mortality in elderly people (1995) (3)
- Platelet aggregation and plasma levels of acetylsalicylic acid in stroke patients on long-term treatment with an enteric-coated aspirin formulation (2004) (3)
- SYMPATHETIC REGULATION OF THYROID HORMONE SECRETION (1975) (3)
- Clinical pharmacokinetics of sulfonylureas: a brief review. (1983) (3)
- Plasma chlorpropamide: A critical factor in chlorpropamide-alcohol flush (2004) (3)
- In vitro and in vivo evaluation of controlled-release and enteric-coated formulations of sodium salicylate. (1984) (3)
- Pricing and Costs of Drugs in the United States and Sweden: A Comparison Based on Drug Acquisition Costs at the Patient Outcome Level (2004) (3)
- Studies on the thyroid activity in the mouse. I. The effects of thyroxine, corticosteroids, hypophysectomy, and changes in environmental temperature. (1968) (3)
- Influence of indomethacin and of polyphloretin phosphate fractions on in vivo secretion of thyroid hormone in mice. (1977) (3)
- 35th Annual Meeting of the European Association for the Study of Diabetes (2016) (3)
- Influence of food intake on antihypertensive drugs: spironolactone. (1983) (3)
- Out-patient antihypertensive drug utilization and stroke mortalityAn ecological study (1996) (3)
- FETAL HEART RATE DURING TREATMENT OF MATERNAL HYPERTENSION WITH BETA-ADRENERGIC ANTAGONISTS. (1984) (3)
- Correlation of drug utilisation and morbidity at the municipality level. High use of antibiotics associated with low use of antihypertensives (2006) (2)
- Comparative dynamics and kinetics of carbimazole and methimazole in man (1978) (2)
- Kinetic interaction of glipizide and indoprofen in healthy volunteers. (1980) (2)
- 1244 – INFLUENCE OF THE SYMPATHETIC NERVOUS SYSTEM ON THYROID HORMONE SECRETION IN MAN (1977) (2)
- [Result of a CPP-project at a primary health care center. Diabetes care in primary health care is resource-demanding]. (2003) (2)
- In vivo absorption of phenytoin from rat small intestine and its inhibition by phlorizin. (2009) (2)
- Newer Concepts in the Therapy of Hypertension (1978) (2)
- Interaction of glipizide and indoprofen. (1981) (2)
- Benzodiazepines and violent deaths (1992) (1)
- Effects of sulfonylurea on the secretion and disposition of insulin and C-peptide. (2009) (1)
- [Can Danish health care registries provide data for specific drug-related hospital admissions in type 2 diabetes?]. (2007) (1)
- [Combination treatment with insulin and metformin in type 2 diabetes. Improves glycemic control and prevents weight gain]. (1999) (1)
- [Regulation of the concentration of thyroid hormones in blood and tissues]. (1978) (1)
- Influence of chronic diflunisal treatment on the plasma levels, metabolism and excretion of indomethacin (1989) (1)
- Pharmacokinetics and Effects of Different Formulations of Glipizide in Patients with Non-Insulin-Dependent Diabetes Mellitus (1993) (1)
- Therapeutic equivalence of sulfaisodimidine 2 g twice daily and 1 g four times daily in lower urinary tract infections. (2009) (1)
- Reduced Body Sway after Physiotherapeutic Treatment of Patients with Dizziness and Cervical Pain (1992) (1)
- In vivo absorption of theophylline and salicylic acid from rat small intestine. (2009) (1)
- Metabolic disorders associated with uncontrolled hypertension (2003) (1)
- Local anaesthesia and immunomodulatory effects of antithyroid drugs. (1984) (1)
- Effects on Lipid and Glucose Metabolism of the Long-Acting β2-Adrenergic Drug Precursor Bambuterol in Patients with Non-Insulin-Dependent Diabetes Mellitus (1993) (1)
- Bioassay of calcitonin by determinations of blood calcium-45 levels in rats and mice. (1973) (1)
- [Focus on proton pump inhibitors. The phenomenon of (over)compensation is not odd but normal]. (2003) (1)
- Fejlmedicinering blandt type 2-diabetikere (2006) (0)
- Electrophysiological and Clinical Evaluation for Early Detection of Diabetic Retinopathy (2010) (0)
- Introduction (1990) (0)
- Glycaemic control in NIDDM patients and its relation to inpatient care utilisation, short-term sick-leave and premature retirement (1998) (0)
- THE RELATION BETWEEN AMINE AND POLYPEPTIDE HORMONE IN CALCITONIN-PRODUCING CELLS (1971) (0)
- [A comment on calcium antagonists: what has been elucidated?]. (2000) (0)
- [Dr Knock's return in reality: "Everyone is sick--but not everyone is aware about that!"]. (2004) (0)
- ON THE ROLE OF AMINE-CONTAINING THYROID MAST CELLS IN THYROID HORMONE SECRETION (1971) (0)
- [Better drug management can improve public health--a study of possible drug interactions by scrutinizing prescriptions dispensing by pharmacies]. (2002) (0)
- Clinical Pharmacology of Anxiolytic-Hypnotic Drugs (1984) (0)
- American Journal of Medicine, November 1983, pp 41-45 Clinical pharmacology of glipizide (1984) (0)
- The use of GP databases in comparative research: the case of diabetes care in Sweden and the Netherlands. (2007) (0)
- Aggregated and individual pharmacy record data. Association between antibiotic and antihypertensive drug use (2008) (0)
- [Hormone secretion from the human thyroid gland studied by a peroperative technic]. (1978) (0)
- [Pharmacological overtreatment in primary care]. (1984) (0)
- British Medical Journal (1871) (0)
- Kinetics-effect relations of glipizide and other sulfonylureas. (1980) (0)
- [Does bromhexine lack expectorating qualities?]. (1978) (0)
- Divergent effects of 6-propylthiouracil on 3,3',5'-triiodothyronine (RT3) serum levels and in man. (1977) (0)
- [Increased risk of cancer with calcium antagonists?]. (1996) (0)
- [Comrades! There must be some blood order in the field of hypertension!]. (2005) (0)
- [Nabumetone is an alternative]. (2003) (0)
- [Bromhexine has no effect]. (1978) (0)
- INFLUENCE OF /-ADRENOCEPTOR BLOCKING AGENTS ON LYMPHOCYTE FUNCTION IN VITRO (2006) (0)
- Absorption of sulfonylurea drugs in patients with type 2 diabetes mellitus (1996) (0)
- Serumtolbutamide andchlorpropamide concentrations in patients withdiabetes mellitus (1978) (0)
- [Extensive public health work in necessary to achieve long-term effects on cardiovascular diseases]. (2005) (0)
- [Does guaiphenesin lack expectorant qualities?]. (1978) (0)
- [A gigantic meta-analysis confirms: thiazides are best as the first choice medication in hypertension; new guidelines are necessary]. (2003) (0)
- [Who is prescribing what and at what cost?]. (1996) (0)
- [Drug information and clinical pharmacology in primary health care]. (1977) (0)
- INFLUENCEOF /-ADRENOCEPTORBLOCKINGAGENTS ON LYMPHOCYTE FUNCTIONINVITRO (1982) (0)
- The British Medical Journal (1886) (0)
- [Drug industry is not to be subsidized by the society]. (2004) (0)
- Benzodiazepines and violent deaths : authors replies (1992) (0)
- [Feared risk factors in connection with calcium antagonists are not to be dismissed]. (1998) (0)
- [Marketing of researchers--lack of judgment or a new trend?]. (2002) (0)
- [Reply 2: nonchalant and fabricated criticism]. (2000) (0)
- [Drug companies should not advertise prescription drugs among the public]. (2001) (0)
- [Prevention goes astray. Stop subsidizing of drugs for primary prevention when other alternatives are available]. (2004) (0)
- OR-24: Antihypertensive calcium channel blockers may promote human cancer cell growth (2003) (0)
- [Reflections on COX, Vioxx and Relifex. Increased cardiovascular risk following selective COX-2 inhibition]. (2004) (0)
- [Five experts interviewed about drugs. Benefits for the patients could have been more emphasized]. (2002) (0)
- Oral antidiabetic therapy. (2009) (0)
- [An announcement from the ALLHAT: Thiazide diuretics are medically and economically superior]. (2003) (0)
- Alteration of thyroid hormone economy during alcohol withdrawal in alcoholics. (1982) (0)
- Low 5-year incidence of retinopathy in subjects with impaired fasting glucose (IFG), the NANSY-Eye Study (2008) (0)
- [Difficult to confirm the reason of the positively reduced number of suicides]. (2003) (0)
- [Renaissance for chlorthalidone]. (2013) (0)
- Can drug treatment prevent disease in common practice? (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Arne Melander?
Arne Melander is affiliated with the following schools:
